KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Change in Accured Expenses (2018 - 2025)

Moderna (MRNA) has disclosed Change in Accured Expenses for 8 consecutive years, with $131.0 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 7.09% to $131.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.0 million through Dec 2025, down 107.69% year-over-year, with the annual reading at -$6.0 million for FY2025, 107.69% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was $131.0 million at Moderna, down from $258.0 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $477.0 million in Q2 2023, with the low at -$495.0 million in Q1 2023.
  • Average Change in Accured Expenses over 5 years is $44.8 million, with a median of $58.0 million recorded in 2022.
  • The sharpest move saw Change in Accured Expenses surged 18300.0% in 2021, then tumbled 1514.29% in 2023.
  • Over 5 years, Change in Accured Expenses stood at -$477.0 million in 2021, then skyrocketed by 171.07% to $339.0 million in 2022, then plummeted by 92.63% to $25.0 million in 2023, then soared by 464.0% to $141.0 million in 2024, then fell by 7.09% to $131.0 million in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $131.0 million, $258.0 million, and -$428.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.